NCT00171990View on ClinicalTrials.gov

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

PHASE3CompletedINTERVENTIONAL
Enrollment

1,461

Participants

Timeline

Start Date

January 31, 2003

Study Completion Date

February 28, 2006

Conditions
Recurrent Genital Herpes
Interventions
DRUG

Famciclovir

Trial Locations (1)

Unknown

Novartis Investigative Site, North Ryde

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY